BALAXI PHARMACEUTICALS
Back to Income Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹48 Cr | ₹37 Cr | ₹6.13 Cr | ₹197 Cr | ₹1.97 Cr |
What is the latest Consolidated Net Profit of BALAXI PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹48 Cr |
Mar2022 | ₹37 Cr |
Mar2021 | ₹6.13 Cr |
Mar2020 | ₹197 Cr |
Mar2019 | ₹1.97 Cr |
How is Consolidated Net Profit of BALAXI PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹48 Cr | 29.41 | |
Mar2022 | ₹37 Cr | 507.51 | |
Mar2021 | ₹6.13 Cr | -96.88 | |
Mar2020 | ₹197 Cr | 9,899.49 | |
Mar2019 | ₹1.97 Cr | - |
Compare Consolidated Net Profit of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹713.5 Cr | 4.6% | 12.2% | 23.1% | Stock Analytics | |
ADANI ENTERPRISES | ₹348,869.0 Cr | 0.8% | 1.3% | 62.1% | Stock Analytics | |
REDINGTON | ₹16,491.5 Cr | -0.5% | -4.5% | 20.4% | Stock Analytics | |
HONASA CONSUMER | ₹13,381.6 Cr | -2.4% | 6.2% | NA | Stock Analytics | |
MMTC | ₹11,224.5 Cr | 5.4% | 6.2% | 147.3% | Stock Analytics | |
MSTC | ₹6,683.8 Cr | 14.8% | 12.2% | 211.4% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | 4.6% |
12.2% |
23.1% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses